Skip to main content

What the FDA labels say about taking them together

Ubrogepant and verapamil

Ubrogepant's FDA label of June 5, 2025 names verapamil in its drug interactions section; the verapamil labels PlainMeds reads (4) do not name ubrogepant. The ubrogepant label: “Co-administration of UBRELVY with verapamil, a moderate CYP3A4 inhibitor, resulted in an increase in ubrogepant exposure.”

Check it at the source: the ubrogepant FDA label on DailyMed (effective June 5, 2025, Allergan, Inc.); the verapamil FDA label on DailyMed (effective April 6, 2026, Zydus Pharmaceuticals (USA) Inc.).

What does the ubrogepant label say about verapamil?

Ubrogepant label, drug interactions

Co-administration of UBRELVY with verapamil, a moderate CYP3A4 inhibitor, resulted in an increase in ubrogepant exposure [see Clinical Pharmacology ( 12.3 ) ].

Source: FDA drug label (UBRELVY), NDA211765 (Abbvie), as published by Allergan, Inc., effective June 5, 2025 (SPL set fd9f9458-fd96-4688-be3f-f77b3d1af6ab), via openFDA; the full label on DailyMed

What does the verapamil label say about ubrogepant?

Verapamil's label (effective April 6, 2026) and its 3 other brand-application labels do not name ubrogepant in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Verapamil hydrochloride), Zydus Pharmaceuticals (USA) Inc., effective April 6, 2026 (SPL set e19ab8d8-dae5-489d-9805-7e7407bea06d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Ubrogepant generic labelers
43Verapamil generic labelers
UbrogepantVerapamil
Labeled forMigraineHigh blood pressure, Atrial fibrillation, Angina
Boxed warningNoNo
Pharmacy cost (NADAC)$109.11 per tablet 100 mg tablet$0.191 per tablet 180 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?